Matricelf Ltd (TA:MTLF) — Market Cap & Net Worth
Market Cap & Net Worth: Matricelf Ltd (MTLF)
Matricelf Ltd (TA:MTLF) has a market capitalization of $20.84 Million (ILA7.77 Billion) as of July 21, 2026. Listed on the TA stock exchange, this Israel-based company holds position #24946 globally and #359 in its home market, demonstrating a 1.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Matricelf Ltd's stock price ILA265.80 by its total outstanding shares 29244761 (29.24 Million). Review how much debt does Matricelf Ltd carry to assess the company's total debt and financial obligations.
Matricelf Ltd Market Cap History: 2021 to 2026
Matricelf Ltd's market capitalization history from 2021 to 2026. Data shows change from $67.46 Million to $20.84 Million (-12.64% CAGR).
Matricelf Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Matricelf Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MTLF by Market Capitalization
Companies near Matricelf Ltd in the global market cap rankings as of July 21, 2026.
Key companies related to Matricelf Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #560 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $480.50 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $672.15 |
| #541 | Argen-X | BR:ARGX | $49.55 Billion | €753.60 |
| #560 | UCB SA | BR:UCB | $47.34 Billion | €238.00 |
Matricelf Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Matricelf Ltd's market cap moved from $67.46 Million to $ 20.84 Million, with a yearly change of -12.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA20.84 Million | -51.75% |
| 2025 | ILA43.19 Million | +50.27% |
| 2024 | ILA28.74 Million | -11.51% |
| 2023 | ILA32.48 Million | -7.15% |
| 2022 | ILA34.98 Million | -48.14% |
| 2021 | ILA67.46 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of Matricelf Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.84 Million USD |
| MoneyControl | $20.84 Million USD |
| MarketWatch | $20.84 Million USD |
| marketcap.company | $20.84 Million USD |
| Reuters | $20.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more